VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
— The new pricing structure is made available as of February for 3.39 EUR per day at pharmacies throughout Finland...
— The new pricing structure is made available as of February for 3.39 EUR per day at pharmacies throughout Finland...
CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated...
CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated...
$15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic...
$15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic...
Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity and metabolic dysfunction-associated steatotic liver disease, tapping into a rapidly...
Innovative non-hallucinogenic treatment combines MEAI with Palmitoylethanolamide to address obesity and metabolic dysfunction-associated steatotic liver disease, tapping into a rapidly...
A German CDO Supporting Biotech Companies Bringing Biologics from Early Development to ClinicMELBOURNE, Australia, March 10, 2026 (GLOBE NEWSWIRE) --...
A German CDO Supporting Biotech Companies Bringing Biologics from Early Development to ClinicMELBOURNE, Australia, March 10, 2026 (GLOBE NEWSWIRE) --...
Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately...
Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately...
All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only pharmacological...
All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only pharmacological...
DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
Clover Health's early adoption of real-time patient access to claims data on Kno2 is made possible by underlying infrastructure powered...
Clover Health's early adoption of real-time patient access to claims data on Kno2 is made possible by underlying infrastructure powered...
Chicago, Illinois--(Newsfile Corp. - March 10, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that...
Live Webcast on Thursday, March 19 at 8:40 am ET to Highlight the Expanding Clinical Experience with the LIBERTY® Endovascular...
Live Webcast on Thursday, March 19 at 8:40 am ET to Highlight the Expanding Clinical Experience with the LIBERTY® Endovascular...